186:
35:
453:
79:
209:
InChI=1S/C22H26N2O6/c1-24-10-9-21-18-12-3-4-14(25)19(18)30-20(21)13(7-8-22(21,28)15(24)11-12)23-16(26)5-6-17(27)29-2/h3-6,13,15,20,25,28H,7-11H2,1-2H3,(H,23,26)/b6-5+/t13-,15-,20+,21+,22-/m1/s1
518:
225:
494:
200:
528:
303:
523:
487:
164:
553:
543:
355:
Portoghese PS, Takemori AE (October 1983). "Different receptor sites mediate opioid agonism and antagonism".
480:
538:
390:
Huang W, Manglik A, Venkatakrishnan AJ, Laeremans T, Feinberg EN, Sanborn AL, et al. (August 2015).
107:
47:
403:
323:
181:
335:
429:
372:
464:
127:
548:
513:
419:
411:
364:
248:
533:
185:
407:
424:
391:
297:
507:
152:
34:
17:
452:
282:
118:
460:
433:
376:
415:
368:
139:
319:
98:
296:
Except where otherwise noted, data are given for materials in their
78:
68:
169:
468:
392:"Structural insights into µ-opioid receptor activation"
233:O=C(OC)\C=C\C(=O)N45Oc1c2c(ccc1O)C3N(CC253(O)CC4)C
151:
488:
8:
495:
481:
184:
126:
26:
423:
347:
230:
205:
180:
212:Key: VYGVQURMYFVOPO-IRYZUVSXSA-N
106:
7:
449:
447:
519:Heterocyclic compounds with 5 rings
142:
467:. You can help Knowledge (XXG) by
25:
451:
266:
260:
33:
300:(at 25 °C , 100 kPa).
357:Journal of Medicinal Chemistry
272:
254:
1:
326:. It is used experimentally.
55:)-4-{amino}-4-oxo-2-butenoate
570:
446:
294:
241:
221:
196:
60:
46:
41:
32:
463:-related article is a
529:Nitrogen heterocycles
18:Beta-fuoxymorphamine
524:Oxygen heterocycles
416:10.1038/nature14886
408:2015Natur.524..315H
369:10.1021/jm00364a001
290: g·mol
29:
324:μ-opioid receptors
304:Infobox references
28:β-Fuoxymorphamine
27:
476:
475:
316:β-Fuoxymorphamine
312:Chemical compound
310:
309:
165:CompTox Dashboard
80:Interactive image
16:(Redirected from
561:
497:
490:
483:
455:
448:
438:
437:
427:
402:(7565): 315–21.
387:
381:
380:
352:
336:β-Funaltrexamine
289:
274:
268:
262:
256:
249:Chemical formula
189:
188:
173:
171:
155:
144:
130:
110:
82:
37:
30:
21:
569:
568:
564:
563:
562:
560:
559:
558:
554:Analgesic stubs
544:Fumarate esters
504:
503:
502:
501:
444:
442:
441:
389:
388:
384:
354:
353:
349:
344:
332:
313:
306:
301:
287:
277:
271:
265:
259:
251:
237:
234:
229:
228:
217:
214:
213:
210:
204:
203:
192:
182:DTXSID301336209
174:
167:
158:
145:
133:
113:
85:
72:
56:
23:
22:
15:
12:
11:
5:
567:
565:
557:
556:
551:
546:
541:
536:
531:
526:
521:
516:
506:
505:
500:
499:
492:
485:
477:
474:
473:
456:
440:
439:
382:
363:(10): 1341–3.
346:
345:
343:
340:
339:
338:
331:
328:
311:
308:
307:
302:
298:standard state
295:
292:
291:
285:
279:
278:
275:
269:
263:
257:
252:
247:
244:
243:
239:
238:
236:
235:
232:
224:
223:
222:
219:
218:
216:
215:
211:
208:
207:
199:
198:
197:
194:
193:
191:
190:
177:
175:
163:
160:
159:
157:
156:
148:
146:
138:
135:
134:
132:
131:
123:
121:
115:
114:
112:
111:
103:
101:
95:
94:
91:
90:Abbreviations
87:
86:
84:
83:
75:
73:
66:
63:
62:
58:
57:
50:
44:
43:
39:
38:
24:
14:
13:
10:
9:
6:
4:
3:
2:
566:
555:
552:
550:
547:
545:
542:
540:
539:Methyl esters
537:
535:
532:
530:
527:
525:
522:
520:
517:
515:
512:
511:
509:
498:
493:
491:
486:
484:
479:
478:
472:
470:
466:
462:
457:
454:
450:
445:
435:
431:
426:
421:
417:
413:
409:
405:
401:
397:
393:
386:
383:
378:
374:
370:
366:
362:
358:
351:
348:
341:
337:
334:
333:
329:
327:
325:
321:
317:
305:
299:
293:
286:
284:
281:
280:
253:
250:
246:
245:
240:
231:
227:
220:
206:
202:
195:
187:
183:
179:
178:
176:
166:
162:
161:
154:
150:
149:
147:
141:
137:
136:
129:
125:
124:
122:
120:
117:
116:
109:
105:
104:
102:
100:
97:
96:
92:
89:
88:
81:
77:
76:
74:
70:
65:
64:
59:
54:
49:
45:
40:
36:
31:
19:
469:expanding it
458:
443:
399:
395:
385:
360:
356:
350:
315:
314:
108:ChEMBL413090
61:Identifiers
52:
242:Properties
508:Categories
342:References
322:acting at
283:Molar mass
119:ChemSpider
67:3D model (
48:IUPAC name
461:analgesic
51:Methyl (2
434:26245379
330:See also
153:44276202
549:Phenols
514:Opioids
425:4639397
404:Bibcode
377:6312042
288:414.458
140:PubChem
128:8915841
534:Amides
432:
422:
396:Nature
375:
320:opioid
318:is an
226:SMILES
99:ChEMBL
93:β-FOA
42:Names
459:This
201:InChI
69:JSmol
465:stub
430:PMID
373:PMID
420:PMC
412:doi
400:524
365:doi
170:EPA
143:CID
510::
428:.
418:.
410:.
398:.
394:.
371:.
361:26
359:.
264:26
258:22
496:e
489:t
482:v
471:.
436:.
414::
406::
379:.
367::
276:6
273:O
270:2
267:N
261:H
255:C
172:)
168:(
71:)
53:E
20:)
Text is available under the Creative Commons Attribution-ShareAlike License. Additional terms may apply.
